Zotarolimus-Eluting Stent vs. Sirolimus-Eluting Stent vs. Paclitaxel-Eluting Stent for Acute Myocardial Infarction Patients - ZEST-AMI — Presented at TCT 2008


A number of studies have demonstrated the superiority of sirolimus-eluting (SES) or paclitaxel-eluting stents (PES) over bare-metal stents (BMS) in patients presenting with ST-elevation myocardial infarction (STEMI). This trial sought to compare the safety and efficacy of zotarolimus-eluting stents (ZES) with SES and PES in patients presenting with STEMI.